Comentarios clínicosEl ligando CD40 soluble: marcador potencial de riesgo cardiovascularSoluble CD40 ligand: a potencial marker of cardiovascular risk
Bibliografía (27)
- et al.
The CD40 ligand, gp 39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome
Cell
(1993) - et al.
Therapeutic criteria in the acute coronary syndrome
Rev Clin Esp
(2004) Mediadores de inflamación de aterosclerosis: el papel del ligando CD40
Actualidades en el Laboratorio Clínico
(2004)Atherosclerosis. An inflammatory disease
N Engl J Med
(1999)- et al.
Mecanismos principales de estabilización de la placa aterosclerótica mediante reducción lipídica
Cardiovascular Risk Factor
(2000) - et al.
The unstable atheroma
Arterioscler Thromb Vasc Biol
(1997) - et al.
Endothelial cells in inflammation
- et al.
Matrix metalloproteinases and coronary artery disease: a novel therapeutic target
J Clin Pharmacol
(1997) - et al.
Tissue factor in the pathogenesis of atherosclerosis
Thromb Haemost
(1997) - et al.
Membrane type I matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators
Circulation
(1999)
Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis
Proc Natl Acad Sci USA
(1997)
Síndromes coronarios agudos. Evaluación del riesgo oculto
Rev Costarric Cardiol
(2004)
Cited by (0)
Copyright © 2007 Sociedad Española de Medicina Interna (SEMI) and Elsevier España, S.L. All rights reserved.